Resources
Nanopharm Resources
As a leader in the field of developing and testing nasal and inhaled drug delivery products, Nanopharm is committed to advancing scientific knowledge in this specialized area. Our team of dedicated scientists conduct cutting-edge research, and we are excited to share our content with you. By sharing our scientific publications webinars and white papers, we aim to foster a spirit of collaboration, inspire new ideas, and contribute to the collective knowledge of the OINDP scientific community. We encourage you to explore our resources page but please visit this section at regular intervals as our team continues to share the latest scientific articles with you.
11 February 2025
Advancing Alternative Bioequivalence for OINDPs
Bioequivalence, Nanopharm, OINDPs
Filter Resources By
03 Nov 2021
Aerodynamic, Antigen, Dry Powder, GLA, Human Papillomavirus, Inhalation, Nanopharm, Performance, Vaccine
11 Jan 2021
drug delivery, Inhalation, Low GWP, Nanopharm, pMDIs, Propellants, Valve and Actuator
04 Jan 2021
Container Closure System, Nanopharm, pMDIs, Salmeterol Xinafoate, Valve Types
09 Jan 2020
DPI, Drug Absorption, Dry powder inhaler, Generic, In Silico, Nanopharm, Tiotropium
07 Jan 2020
Bioequivalent, COPD, DPI, Glycopyrrolate, In Silico, In Vitro, Indacaterol, Nanopharm
12 Jul 2019
Annealing, DPI, Drug Development, Dry powder inhaler, Micronized, Molecular SFE, Nanopharm
01 Feb 2016
bioequivalence, drug delivery, In Vitro, Nanopharm, Nasal, Particle Size
01 Sep 2015
Computational Fluid Dynamics, DPIs, Dry Powder Inhalers, In Vitro, Nanopharm, particle size distribution
01 Jun 2015
APSD, DPI, Dry powder inhaler, Fluticasone Propionate, Nanopharm, Structural Dynamics
